• Meta-analysis
  • Treatment: Exercise & Movement
  • Systematic Reviews & Meta-analyses
  • Comorbidities & Related Conditions
Clinical RelevanceDOI 4 min read
Jump to:

Patient-friendly summary

If you read nothing else

Pooling trials of fibromyalgia patients, this review found that regular exercise may reduce pain, ease depression, and improve quality of life — with aerobic and strengthening work helping most for pain.

Bottom line

Therapeutic exercise — particularly aerobic and muscle-strengthening, with combined programs best for mood — appears to reduce pain, FMS severity, and depressive symptoms and to improve quality of life, but small, heterogeneous, mostly-female studies mean the best exercise type remains uncertain.

Moderate evidence

Published

2017
9 years ago
Older study

Evidence hierarchy

Meta-analysis ◀ this study
Systematic Review
RCT
Cohort
Case-Control
Case Report
Expert Opinion

Study participants

715 participants (16 RCTs included qualitatively; 14 in the meta-analysis)Average age 42.36 years700 women (97.9%) and 15 men (2.1%)

Adults diagnosed with fibromyalgia syndrome without significant comorbidity, recruited across Norway, the UK, Brazil, Spain, the US, Sweden, and Turkey

Full research — for clinicians and curious readers

Study Summary

This systematic review and meta-analysis pooled randomized controlled trials of therapeutic exercise (aerobic, strengthening, stretching, and combined) for adults with fibromyalgia syndrome (FMS). Drawing on 16 RCTs (14 in the quantitative analysis; 715 participants, almost all women), it reports that exercise reduced pain, FMS severity, and symptoms of depression while improving both the physical and mental components of health-related quality of life. The authors describe aerobic and muscle-strengthening exercise as most effective for pain and FMS severity, stretching and aerobic exercise as most helpful for quality of life, and combined exercise as most effective for depressive symptoms. They caution that the included studies were small and heterogeneous, so firm conclusions about which exercise type is best could not be drawn.

72/100
Evidence StrengthStrong
Study Quality
Sample Size
Replication

Key Findings

FindingDetailImpact
Exercise reduced overall pain with a large effect sizePooled standardized mean difference (SMD) of −1.11 (95% CI −1.52 to −0.71; overall effect p < 0.001), described by the authors as strong evidence from both intention-to-treat and per-protocol analyses. Cohen's g indicated a large effect on pain.High
Exercise reduced FMS severity (global well-being) with a medium effectPooled SMD of −0.67 (95% CI −0.89 to −0.45; p < 0.001) on FMS severity measured largely by the Fibromyalgia Impact Questionnaire; classified as a medium effect.High
Exercise reduced symptoms of depression with a small effectPooled SMD of −0.40 (95% CI −0.55 to −0.24; p < 0.001); the authors note combined exercise produced the largest beneficial effect on depressive symptoms (SMD −0.47, medium effect).Medium
Exercise improved both physical and mental components of health-related quality of lifePhysical component SMD 0.77 (95% CI 0.47 to 1.08; p < 0.001) and mental component SMD 0.49 (95% CI 0.27 to 0.71; p < 0.001); medium effect sizes. Stretching produced the largest gain in the physical component of HRQOL.High
Different exercise types appeared best for different outcomesAerobic and muscle-strengthening exercise were described as most effective for reducing pain and FMS severity; stretching and aerobic exercise for improving HRQOL; and combined programs for reducing depression. Stretching alone was not effective for pain or FMS severity in per-protocol analysis.Medium
Heterogeneity was driven by two studies and removing them strengthened the pain effectExcluding the studies by Kayo et al. and Jones et al. eliminated statistical heterogeneity for pain and FMS severity; the pain effect remained large (SMD −0.97, 95% CI −1.39 to −0.55; p < 0.001) and FMS severity strengthened (SMD −1.04).Medium
Study Methodology
Study Design
Systematic review and meta-analysis of randomized controlled trials, conducted per PRISMA and Cochrane Collaboration recommendations; effects pooled as standardized mean differences (Hedge's adjusted g) using a random-effects model with inverse-variance weighting in RevMan 5.3.
Sample Size
16 RCTs included in qualitative synthesis (14 in the quantitative meta-analysis); 715 participants studied before and after treatment
Duration
Literature search performed April 2016 to May 2017; individual trial exercise programs ranged roughly from 4 weeks to 6 months (e.g., aerobic 4–6 months, combined programs 3–6 months)
Population
Adults (older than 18 years) diagnosed with fibromyalgia syndrome without significant comorbidity; predominantly women (700 of 715, 97.9%; 15 men, 2.1%); average age 42.36 years
Outcome Measures
Pain (Visual Analogue Scale; FIQ pain subscale; SF-36 pain subscale; Multidimensional Pain Inventory) · Global well-being / FMS severity (Fibromyalgia Impact Questionnaire total score) · Symptoms of depression (Beck Depression Inventory; Hospital Anxiety and Depression Scale; VAS from FIQ) · Health-related quality of life (SF-36 physical and mental components) · Methodological quality (CONSORT 2010 checklist, inclusion threshold >15/25) and risk of bias (Cochrane Collaboration tool)

Strengths

  • Conducted according to PRISMA and Cochrane Collaboration methodology with a prespecified protocol
  • Comprehensive multi-database search (Cochrane Plus, PEDro, PubMed) plus manual journal searching in two languages
  • Independent dual reviewers for study selection, data extraction, and quality assessment
  • Methodological quality screened with CONSORT 2010 (inclusion threshold >15/25) and risk of bias assessed with the Cochrane tool
  • Random-effects model (conservative) with Hedge's adjusted g to correct for small-study bias
  • Subgroup analyses by exercise type and sensitivity analyses to identify sources of heterogeneity; funnel plot showed no evidence of publication bias

Limitations

  • Small sample sizes in most included trials (typically fewer than 40 subjects per group)
  • Almost all participants were women, so applicability to men with fibromyalgia is uncertain
  • Exercise interventions cannot be blinded, so all studies were rated at high risk of bias for blinding of participants and personnel
  • Substantial heterogeneity, primarily from the Kayo et al. and Jones et al. studies, which must be considered when interpreting results
  • Each exercise type was studied in only a small number of trials, so the authors state they could not firmly conclude which type is most effective
  • The meta-analysis treated post-treatment data as the experimental group and pre-treatment values as the control group, a within-study comparison approach

Key Takeaways for Patients

What This Means for You

  1. Regular exercise may help reduce pain, lessen the overall impact of fibromyalgia, ease low mood, and improve quality of life — the review found benefits across all of these areas.

  2. Aerobic activity (such as walking, cycling, or treadmill) and muscle-strengthening exercise appeared most helpful for pain and overall severity, while stretching and aerobic exercise helped most with quality of life.

  3. Programs combining aerobic, strengthening, and stretching exercise seemed best for improving mood and depressive symptoms.

  4. The reviewed programs were typically mild-to-moderate intensity, 2–3 sessions per week of about 30–45 minutes each.

  5. Benefits tend to fade if you stop, so the authors emphasize keeping up regular activity over time; talk with your clinician about a program that fits you.

  6. Because nearly all participants were women, it is not certain how well these results apply to men with fibromyalgia.

Read the Full Paper

Access the complete peer-reviewed study from BioMed Research International

View Full Study

Related Research

●●●●● LandmarkSystematic Review

Effectiveness of Percutaneous Needle Electrolysis (PNE) and Intramuscular Electrical Stimulation (IMES) in the Management of Myofascial Pain Syndrome and Tendinopathies: A Systematic Review

Trybulski et al.·Journal of Clinical Medicine·2026

This systematic review found that PNE and IMES may improve pain and function in myofascial pain syndrome and tendinopathies, but evidence quality was limited by high risk of bias. Both techniques appear safe with only minor, self-limiting adverse events.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkSystematic Review

Dry Needling in Sports and Sport Recovery: A Systematic Review with an Evidence Gap Map

Kużdżał et al.·Sports Medicine·2025

This systematic review of 24 studies found dry needling effectively reduces pain in injured athletes but shows mixed results for performance enhancement in healthy athletes. Significant research gaps exist for elite athletes and long-term effects.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkMeta-analysis

Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis

Anna Pathak et al.·Rheumatology (Oxford)·2025

A meta-analysis of randomized trials in fibromyalgia found that CBT for insomnia moderately improved sleep quality, while most common drugs showed little to no benefit and pregabalin and sodium oxybate helped modestly but carried risks.

Comorbidities & Related ConditionsRead →
●●●●● LandmarkMeta-analysis

Comparative effectiveness of noninvasive therapeutic interventions for myofascial pain syndrome: a network meta-analysis of randomized controlled trials

Liu et al.·International Journal of Surgery·2024

Network meta-analysis of 40 RCTs found manual therapy, laser therapy, and extracorporeal shock wave therapy most effective for reducing pain and disability in myofascial pain syndrome. These three treatments showed benefits across pain intensity, pressure pain threshold, and functional outcomes comp

Systematic Reviews & Meta-analysesRead →